Literature DB >> 19429125

Inhibition of lysosomal functions reduces proteasomal activity.

Liyan Qiao1, Jianhua Zhang.   

Abstract

Protein accumulation and aggregation are signatures of several major neurodegenerative diseases. Proteasomal- and lysosomal-mediated protein degradation pathways are the two major pathways for intracellular protein degradation. Cross-regulation between these two pathways may be important for protein homeostasis. Pharmacological inhibition of proteasomal activities has been shown to up-regulate the levels of lysosomal enzymes. To determine whether the reverse regulatory mechanism also occurs in the cell, we investigated the effects of inhibition of lysosomal function on proteasomal activities. We found that rather than up-regulating proteasomal activities in response to lysosomal disruptors, reduced lysosomal function reduces proteasomal functions, indicating a lack of compensatory up-regulation of proteasomal functions. Inhibition of lysosomal or proteasomal activities led to higher levels of chaperone heat shock cognate protein Hsc70, suggesting an attempt to compensate protein degradation deficiency by enhancing chaperone-mediated autophagy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429125     DOI: 10.1016/j.neulet.2009.03.085

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

1.  HSP70 inhibition by the small-molecule 2-phenylethynesulfonamide impairs protein clearance pathways in tumor cells.

Authors:  J I-Ju Leu; Julia Pimkina; Pooja Pandey; Maureen E Murphy; Donna L George
Journal:  Mol Cancer Res       Date:  2011-06-02       Impact factor: 5.852

2.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

Review 3.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

4.  Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62.

Authors:  Natura Myeku; Maria E Figueiredo-Pereira
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

5.  Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.

Authors:  Darius Ebrahimi-Fakhari; Ippolita Cantuti-Castelvetri; Zhanyun Fan; Edward Rockenstein; Eliezer Masliah; Bradley T Hyman; Pamela J McLean; Vivek K Unni
Journal:  J Neurosci       Date:  2011-10-12       Impact factor: 6.167

6.  Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease.

Authors:  Lonnie Schneider; Jianhua Zhang
Journal:  Mol Neurodegener       Date:  2010-04-13       Impact factor: 14.195

7.  High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).

Authors:  Itsuki Yamaguchi; Shige H Yoshimura; Hironori Katoh
Journal:  J Biol Chem       Date:  2020-04-07       Impact factor: 5.157

8.  Over-expression of an inactive mutant cathepsin D increases endogenous alpha-synuclein and cathepsin B activity in SH-SY5Y cells.

Authors:  Donna Crabtree; Matthew Dodson; Xiaosen Ouyang; Michaël Boyer-Guittaut; Qiuli Liang; Mary E Ballestas; Naomi Fineberg; Jianhua Zhang
Journal:  J Neurochem       Date:  2013-11-13       Impact factor: 5.372

9.  A unique carboxyl-terminal insert domain in the hematopoietic-specific, GTPase-deficient Rho GTPase RhoH regulates post-translational processing.

Authors:  Anja Troeger; Hee-Don Chae; Mumine Senturk; Jenna Wood; David A Williams
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

Review 10.  DangER: protein ovERload. Targeting protein degradation to treat myeloma.

Authors:  Lauren I Aronson; Faith E Davies
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.